TrialAddiction (Abingdon, England)2019

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder.

Michael Frost et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.